The bottle says Neurontin. The last one said gabapentin. Did they switch me?
Why the 300 mg capsule is a start, not a destination
I open the Neurontin card on the first capsule, not on the ceiling.
Reviews of Neurontin 300 mg that treat the capsule as a finished dose are half a note. Three hundred milligrams is the usual first swallow for nerve pain on the immediate-release form. Day two is often 300 mg twice. Day three is 300 mg three times. The climb toward something like 1,800 mg a day happens over days to weeks, not over one evening.
The label allows up to 3,600 mg a day in divided doses. Many people never need that ceiling. Starting at a target dose is how dizziness and unsteadiness win the first week and the patient stops the drug before it had a chance. I would rather a slow climb than a heroic first bottle.
Older adults and anyone with a quietly reduced eGFR start lower still. A 300 mg capsule that looks modest on a young kidney is a sedating load on an eighty-year-old clearance of 25. That is why this desk locks the SERP story on 300 mg as a start and a titration unit, not as a personality.
A GABA name that never sat on the receptor
Chemists in the 1970s wanted a GABA mimic that could cross into the brain. They bolted GABA onto a ring. The molecule crossed. It never engaged GABA receptors in any way that explains the clinic. The real target showed up later: alpha-2-delta on voltage-gated calcium channels.
Binding that subunit reduces calcium entry at overexcited terminals. Less glutamate, less substance P, less noradrenaline dumped into the gap. Noisy nerves quiet down. Ordinary inflammatory ache does not run through that channel, which is why this capsule disappoints people who brought a mechanical back to a nerve-pain drug.
The name still fools clerks and patients. I write 'not GABA' in the margin every time. It is the single most common misconception I meet, and it is also why people expect a benzodiazepine hug and instead get a slower, stranger quiet.
1993 seizures, 2002 shingles pain, 2004 settlement
1970s
Designed as a GABA analogue to cross into the brain. The receptor premise was wrong.
1993
FDA approves Neurontin as add-on therapy for partial seizures.
Late 1990s
Off-label promotion drives volume far past the stamp.
2002
Postherpetic neuralgia approval. A real nerve-pain indication.
2004
Settlement over illegal off-label marketing.
2011 on
Gralise and Horizant refine the clock. Not interchangeable with the capsule.
The FDA approved gabapentin in 1993 as add-on therapy for partial seizures. A modest stamp. What followed was a marketing wave that outran the evidence and produced a 2004 legal settlement over illegal off-label promotion. I keep that date on the card so nobody pretends the prescription volume was all trial-earned.
Postherpetic neuralgia earned a legitimate pain stamp in 2002. That is the nerve-pain home ground. An extended-release tablet, Gralise, and a prodrug, Horizant, arrived later for specific uses. They are not milligram twins of the immediate-release capsule. Do not swap them on a rumor.
The longer arc - Parke-Davis, the ads, the settlement - sits in how a GABA mimic became Neurontin 300 mg. This monograph stays on the climb and the kidney box.
Alpha-2-delta quiets a noisy terminal
Seizure foci and injured nerves share a habit: they fire too much. Gabapentin turns the volume down at the terminal by limiting calcium influx. It does not sedate the whole brain the way a night-time hypnotic does, which is why some people stay functional on a dose that still takes the edge off burning pain.
The effect builds with titration. The first 300 mg capsule is a probe, not a verdict. Abrupt removal after weeks of damping lets that excitability rebound. Anxiety, insomnia, sweating, and in the worst rooms a seizure. That is the mechanistic root of the taper rule I will not drop.
Diabetic neuropathy and post-shingles pain sit on this mechanism. A fresh surgical incision does not. I will not use this capsule as a fast rescue tablet. If the pain is mechanical, I say so and I look elsewhere rather than climbing to 3,600 mg out of stubbornness.
Kidneys run this dose, not the liver
Absorption
Oral. Saturable gut transporter, so bioavailability falls as a single dose rises. Split the day. Food is minor.
Distribution
Reaches the central nervous system as intended. Low protein binding. Peak a few hours after a swallow.
Metabolism
Essentially none. Not a CYP substrate. Pharmacokinetic clashes are few.
Excretion
Renal, unchanged. Half-life about 5-7 hours if kidneys work. Dialysis removes it; give a post-session supplement.
Gabapentin is not metabolized. The liver does not break it down. The kidneys send it out unchanged. If clearance falls, the drug piles up. What walks into clinic is a confused, unsteady older person who was dosed as if the kidneys were forty. I estimate creatinine clearance. I do not eyeball a 'normal' serum creatinine on a small eighty-year-old.
Absorption has its own trap. A saturable gut transporter means bioavailability falls as a single swallow grows. A small dose gets in well. A large single swallow wastes a fraction. That is why the day is split three ways on the immediate-release form, and why doubling one capsule does not double the effect. Food is a minor player.
Half-life with working kidneys is about five to seven hours. Three-times-daily is not a personality quirk. In impairment the half-life stretches. Hemodialysis pulls the drug out; a post-session supplement usually replaces what the machine washed away. Cytochrome interactions are scarce. The dangerous interactions are shared sedation, not enzyme fights.
Climbing 300 mg without skipping the midday
| Day / phase | Immediate-release | Margin |
|---|---|---|
| Day 1 | 300 mg once | Bedtime blunts the first dizzy hour |
| Day 2 | 300 mg twice | Morning and evening |
| Day 3 | 300 mg three times | Set the three-times-daily rhythm |
| Days to weeks | Toward ~1,800 mg/day | Split in three; watch unsteadiness |
| Label ceiling | Up to 3,600 mg/day | Divided; many people never need it |
A typical adult nerve-pain start is 300 mg at bedtime on day one, 300 mg twice on day two, 300 mg three times on day three. Then a slow climb toward about 1,800 mg a day split in three, watching dizziness the way you would watch a wet floor. The label maximum is 3,600 mg a day in divided doses. Many people live well below it.
Missing the midday dose is the quiet reason a patient says the capsule stopped working. The level drops. Pain breaks through. I would rather move the clock to fit a life than pretend a once-daily lump will absorb the same way. It will not.
Renal bands rewrite both the amount and the frequency. Above about 60 mL/min, the usual climb applies. Between 30 and 59, the daily total is roughly halved and given less often. Between 15 and 29 it drops again. Below 15 it drops again. The worked examples live in titrate gabapentin 300 mg after you check the eGFR.
Where a 300 mg x 90 bottle is priced
| Pharmacy | Fill | Cash quote |
|---|---|---|
| Costco Pharmacy | 300 mg x 90 | $5.11 |
| Walgreens Pharmacy | 300 mg x 90 | $11.29 |
| Target (CVS Pharmacy) | 300 mg x 90 | $29.23 |
| H-E-B Pharmacy | 300 mg x 90 | $8.68 |
Generic gabapentin is cheap when the counter is honest and expensive when nobody asked. Brand Neurontin is a different ticket. Reviews of Neurontin 300 mg that skip the cash line leave people paying a retail average near $150 for ninety capsules when a named chain will fill the same bottle for pocket change.
I pulled four counters that actually sit on U.S. maps. Costco warehouse cash for gabapentin 300 mg x 90 printed at $5.11 on a 2026 pharmacy price table. Walgreens sat at $11.29 on a SingleCare coupon for ninety 300 mg capsules. Target pharmacies run as CVS; SingleCare's twelve-month typical there was $29.23 for the same ninety. H-E-B printed $8.68 on WellRx for ninety 300 mg capsules.
Coupon sites stay in this caption. The href is the chain. No Rite Aid. This desk does not sell capsules. Ask the named counter for today's number before you treat a blog cell as a promise.
Reviews that hold - and reviews that do not
Adjunct gabapentin reduced partial-seizure frequency enough to earn the 1993 stamp. Those were sound, modest trials. I trust them as add-on evidence, not as a solo-epilepsy story.
Postherpetic neuralgia is the stronger pain file. Randomized, placebo-controlled trials showed lower daily pain scores and better sleep. Diabetic neuropathy, off-label in the U.S., has a similar placebo-beating pattern. Those are the reviews I will stand on.
Chronic mechanical low back pain, sciatica without a clear nerve signature, and generalized anxiety have thinner, mixed, or disappointing trials and a huge prescription habit. I say that out loud. Climbing a 300 mg capsule for a mechanical ache is how this drug earned a reputation it did not fully pay for. The sorted rows are in what Neurontin 300 mg actually treats, and what it does not.
The 2019 breathing line with opioids
| Agent | Concern | Step |
|---|---|---|
| Opioids | Serious or fatal respiratory depression (FDA 2019) | Avoid or use lowest doses; counsel and watch |
| Benzodiazepines / alcohol | Added CNS depression and falls | Do not stack for sleep |
| Muscle relaxants, sedating antihistamines | Added drowsiness | Caution, especially in older adults |
| Al/Mg antacids | Less gabapentin absorbed | Separate by about 2 hours |
Because the liver does not touch this molecule, people call it interaction-free. It is not. The danger is shared central depression. In 2019 the FDA warned that gabapentinoids plus opioids, or plus other CNS depressants, can slow breathing to a dangerous, sometimes fatal, point. Opioids also raise gabapentin absorption a little. The stack is real.
Benzodiazepines, sedating antihistamines, muscle relaxants, and alcohol sit on the same additive line. Falls in older adults are the quiet harm. Aluminum- or magnesium-containing antacids cut absorption; separate them by about two hours. That is almost the whole pharmacokinetic list.
When both an opioid and gabapentin are truly needed, I start low, climb slower, and tell someone at home what oversedation looks like: unusual sleepiness, confusion, slow shallow breaths. That is an emergency, not a wait-and-see.
Taper, misuse, and the state-monitor footnote
Gabapentin is not a federal controlled substance. Several states now monitor or schedule it anyway. At high doses, or in people with a substance-use history, it can feel sedating, euphoric, or dissociative. It turns up beside opioids in overdose deaths. I do not pretend the old 'no abuse potential' line still holds.
Physical dependence is a separate fact. It happens in people who took the capsule exactly as written. The nervous system adapts to the quiet. Pull the drug away suddenly and the quiet rebounds. Insomnia, sweat, nausea, agitation, and in epilepsy or on high doses a seizure. That is adaptation, not a moral story. It still needs a plan.
Taper over at least a week, longer after high doses or long use. Hospital pauses and 'it was not helping so I stopped' are the two rooms where this still goes wrong. Plan the way down the way you planned the 300 mg climb.
File: what I keep on the Neurontin card
Read the eGFR. Margin the 300 mg start and the opioid list. Peer-line the taper before anyone calls the drug a failure. File the climb only after those marks exist. Three times a day on the immediate-release form. Antacids two hours away.
Reviews of Neurontin 300 mg that skip the kidney box or the 2019 breathing line are advertisements. The 300 mg x 90 cash quotes above are teaching numbers. This site does not fill a bottle.
Talk with your own clinician or pharmacist before you change a dose or stop. This note is education. It is not a prescription.
Forum
The clinic thread
Answered by Dr. Helena Vasquez, PharmD · Clinical pharmacology & drug safety
Mail I keep on Neurontin is almost always the 300 mg climb, a kidney number, or a cold stop. Named readers. Not your chart.
Same molecule. Gabapentin is the generic name. Neurontin is one brand. Gralise is an extended-release cousin and Horizant is a prodrug. Those two are not dose-twins of the immediate-release 300 mg capsule. If the tablet shape or the clock on the label changed, do not assume the climb is the same. Bring both bottles. I will match them before anyone keeps swallowing.
My kidneys are not what they were. Does that change a 300 mg start?
It can change the whole card. Gabapentin leaves only through the kidneys. When clearance falls, the drug piles up and the first things you notice are dizziness, fog, and unsteadiness - the fall that puts an older person in hospital. We dose to creatinine clearance, not to a slogan. A 300 mg three-times-daily habit that is safe at 90 mL/min is too much at 25. Make sure whoever writes the capsule has a recent kidney number, not last year's.
I keep forgetting the midday 300 mg. Does that matter?
It matters more than with many drugs. The gut transporter saturates, so three smaller swallows get in better than one lump, and the half-life is short enough that a missed noon dose leaves a hole. Pain breaks through. People then decide the capsule failed. If noon is impossible, tell me. We can move the clock or talk about a different form. Do not invent a once-daily pile to make the day tidier.
I also have an opioid for my back. Can I take both?
This is the combination I worry about most. Gabapentin plus an opioid can slow breathing, and the FDA said so in 2019. Both quiet the drive to breathe. Opioids also let you absorb a bit more gabapentin. It does not always mean a lifetime ban, but it means the lowest doses that work, a slow climb, and someone at home who knows the warning signs: unusual sleepiness, confusion, slow shallow breaths. Those are an emergency. The FDA warning is the document I point to.
It is not helping. Can I just stop the 300 mg capsules?
Please do not stop cold. Even a tidy prescribed course adapts the nervous system. Pull it away suddenly and you can get anxiety, insomnia, sweat, nausea, agitation, and in some rooms a seizure. That is not a character flaw. It is physiology. Taper over at least a week, longer if the daily total is high or the months are many. Come in and we will write the step-down the way we wrote the climb.
I heard gabapentin gets misused. Should I be worried?
The honest answer moved. For years the line was 'little abuse potential,' and federally it is still not scheduled. Some states now monitor it. At high doses, or with a substance-use history, it can feel sedating or euphoric, and it shows up beside opioids in overdose deaths. For most people on a sensible 300 mg climb for real nerve pain it is not a craving drug. The need to taper is a separate, very real fact. I take both seriously.
I have been dizzy and foggy since the first 300 mg. Is that the drug or my kidneys?
It can be either, and the first week is the noisiest. Dizziness, drowsiness, unsteadiness, a mental fog, sometimes blurred vision - those are the common effects while the dose is rising. In older adults that unsteadiness is a fall. If it is not easing after a week or two, or you feel truly unsafe on your feet, tell me. That can mean the climb outran your clearance. MedlinePlus lists the usual effects in plain language.
Do reviews of Neurontin 300 mg support regular back pain?
For ordinary mechanical back pain, the reviews are weak, and I would rather say that than let you climb for months for nothing. This capsule earns its keep on nerve-generated pain - burning, shooting, post-shingles, diabetic damage. Plain ache and sciatica without a clear nerve signature have not held up well. If your pain has that electric quality, a 300 mg start is reasonable. If it is a mechanical ache, we should look elsewhere before we invent a higher dose.
I am on dialysis. How do you handle the capsule?
Two moves. Because your kidneys are not clearing the drug, the standing dose stays low. Dialysis then washes gabapentin out, so we usually give a supplemental dose after each session. Do not improvise that pair. The dialysis team and the prescriber should set it together. If you feel very drowsy or unsteady between runs, say so. That often means the standing dose needs a trim, not a pep talk.
Can I take my antacid with the 300 mg capsule?
Separate them by about two hours. Aluminum- or magnesium-containing antacids cut how much gabapentin you absorb. Swallow them together and the capsule underperforms, which is a silly way to decide the drug failed. This is one of the few true absorption clashes. The liver is not in the fight. Still bring the full over-the-counter list. I have been surprised before.
How is this different from Lyrica?
Same target, cleaner clock on pregabalin. Lyrica absorbs through a path that does not saturate, so twice-daily dosing and a faster climb are normal. Gabapentin needs three-times-daily and a slower 300 mg climb because the gut transporter fills up. Both are kidney-cleared. Both need the opioid caution and a taper. Lyrica is Schedule V federally. Gabapentin is not, though some states watch it. Cost often favors generic gabapentin. Neither wins every nerve.
My clinician started 300 mg for anxiety. Is that a use you like?
It is a common use and a thin file. A few people feel calmer. The trials for generalized anxiety are not in the same league as the postherpetic neuralgia data. If it is genuinely helping and you tolerate it, that counts. I still apply the same rules: kidney dosing, no casual opioid stack, no cold stop. I would not let it replace a treatment with better evidence if the anxiety is the main illness. Mayo Clinic keeps a balanced overview.
Why does a 300 mg x 90 bottle cost $5 at one counter and $30 at another?
Because generic gabapentin is a commodity and chains still post wildly different cash tickets. On this note I quoted Costco at $5.11 for ninety 300 mg capsules, H-E-B at $8.68, Walgreens at $11.29 on a SingleCare coupon, and Target's CVS counter at a $29.23 twelve-month typical. Retail averages sit near $150 if nobody asks. Coupon boards are comparison tools. Ask the named counter. This desk does not fill the bottle.
General education from a clinician, not personal medical advice. Bring your own history to your own prescriber.
Last Updated